X T L Biopharmaceuticals reported $761K in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Bioline Rx USD 13.62M 1.5M Mar/2026
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026
X T L Biopharmaceuticals USD 761K 1.45M Jun/2025